Articles From: Ventas and American Realty Capital Healthcare Trust, Inc. Announce Definitive Election Deadline for HCT Stockholders to Make an Election to Receive Cash or Stock in the Merger to EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches in India


2015/1/7
Ventas, Inc. (NYSE: VTR) (“Ventas”) and American Realty Capital Healthcare Trust, Inc. (NASDAQ: HCT) (“HCT”) today announced that the definitive election deadline for HCT’s stockholders to make an election to receive cash consideration, stock consideration or a combination of both, subject to proration, for their shares of HCT common stock upon completion of the merger of HCT with and into a wholly owned subsidiary of Ventas, pursuant to the Agreement and Plan of Merger, dated as of June 1, 2014, as amended (the “Merger Agreement”), by and among Ventas, HCT, Stripe Sub, LLC, Stripe OP, LP and American Realty Capital Healthcare Trust Operating Partnership, L.P., will be 5:00 p.m. Eastern Time on January 14, 2015 (the “Election Deadline”). For HCT stockholders to make a timely election, a properly completed letter of election and transmittal must be received by Wells Fargo
Sign-up for Ventas and American Realty Capital Healthcare Trust, Inc. Announce Definitive Election Deadline for HCT Stockholders to Make an Election to Receive Cash or Stock in the Merger investment picks
2015/1/26
By Sue Chang and Mark DeCambre, MarketWatch Microsoft, TI earnings in focus SAN FRANCISCO (MarketWatch) -- These are the stocks making notable moves on Monday: Decliners Mattel Inc. (MAT) said Monday Chief Executive Bryan Stockton has resigned after three years as the toy company continued to struggle in the wake of dwindling popularity of the Barbi doll.
Sign-up for UPDATE: Mattel slumps on CEO exit; D.R. Horton beats on home sales investment picks
2014/12/8
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today the presentation of results from the company’s Phase 1 trial of EPZ-5676, a potent and selective inhibitor of the DOT1L histone methyltransferase (HMT). Epizyme, along with its partner Celgene, is developing EPZ-5676 for the treatment of acute leukemia with alterations in the MLL gene (MLL-r) or partial tandem duplications within MLL (MLL-PTD). The trial found that EPZ-5676 was generally safe and well tolerated across all dose cohorts and showed clinical and biological activity.
Sign-up for Epizyme DOT1L Inhibitor EPZ-5676 Shows Clinical and Biological Activity in Adult Patients with Acute Leukemias in Phase 1 Trial investment picks
2014/12/1
Capital Senior Living Corporation (the “Company”) (NYSE:CSU), one of the country’s largest operators of senior living communities, today announced that management will make a presentation regarding the Company at the 25 th Annual Oppenheimer Healthcare Conference at the Crowne Plaza Hotel on Wednesday, December 10, 2014 at 1:00 p.m. Eastern time.
Sign-up for Capital Senior Living Corporation to Present at the 25th Annual Oppenheimer Healthcare Conference on Wednesday, December 10, 2014 investment picks
2014/12/2
NEW YORK , Dec.
Sign-up for IPG Photonics, TreeHouse Foods Set to Join the S&P MidCap 400; OFG Bancorp to Join the S&P SmallCap 600 investment picks
2015/1/5
Alliance Combines Amgen's Oncology Targets and Kite's Leading CAR T Cell Therapy Platform to Develop new Therapeutic Candidates Kite to Receive a $60 Million Upfront Payment From Amgen and Eligible for up to $525 Million in Regulatory and Sales Milestone Payments per Amgen Program; Plus, Tiered High Single- to Double-Digit Royalties for Sales and License of Kite's Intellectual Property for CAR T Cell Products Amgen Eligible to Receive up to $525 Million in Milestone Payments per Kite Program; Plus, Tiered Single-Digit Sales Royalties Kite to Host Conference Call Today at 4:00 PM Eastern Time THOUSAND OAKS, Calif.
Sign-up for Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies investment picks
2015/1/14
-- Fourth quarter placements of Catalyst® and premium hematology analyzers in total increased 21% --
Sign-up for IDEXX Instrument Placement Momentum Reinforces Strong Organic Revenue Growth Outlook investment picks
2015/1/8
--Transactions transform Egalet into a commercial specialty pharmaceutical company paving the way for commercialization of late-stage pipeline of abuse-deterrent opioids -- --
Sign-up for Egalet Acquires/Licenses Two Innovative Approved Pain Products investment picks
2014/12/2
NEW YORK, Dec.
Sign-up for Auryxia(TM) (Ferric Citrate) Phase 2 Data Published in the American Journal of Kidney Disease investment picks
2015/1/6
InvenSense, Inc. (NYSE: INVN), the leading provider of intelligent sensor solutions, announced that since starting shipment of MEMS-based sensors in late 2006, it will reach 1 billion devices shipped in Q1 of calendar 2015.
Sign-up for InvenSense® to Ship Over 1 Billion MEMS Sensors Worldwide investment picks
2014/12/3
ORLANDO, Fla., Dec.
Sign-up for Photo Release -- Embassy Suites Orlando - Lake Buena Vista Resort Welcomes Guests After $13 Million Renovation investment picks
2015/1/28
DHX Media to Host Fiscal 2015 Second Quarter Analyst Call on Tuesday, February 17, 2015 at 8:00 a.m. ET Canada NewsWire HALIFAX , Jan.
Sign-up for DHX Media to Host Fiscal 2015 Second Quarter Analyst Call on Tuesday, February 17, 2015 at 8:00 a.m. ET investment picks
2014/12/4
Houghton Mifflin Harcourt announced today that it will publish a new title by New York Times bestselling authors Melissa and Dallas Hartwig.
Sign-up for Houghton Mifflin Harcourt Acquires The Whole30: A Step-by-Step Guide to the Health Movement Sweeping the Nation investment picks
2015/1/13
By Jennifer Booton, MarketWatch Chinese smartphone vendors now comprise 30% of global volume NEW YORK (MarketWatch) -- With Apple Inc. selling a record number of iPhones in the fourth quarter, one would think the market for smartphones would be hotter than ever.
Sign-up for UPDATE: 5 predictions for mobile devices in 2015 investment picks
2014/12/3
CIT Group Inc. (NYSE:CIT) cit.com , a leading provider of commercial lending and leasing services, today announced that John A.
Sign-up for CIT to Present at the Goldman Sachs US Financial Services Conference 2014 on December 9, 2014 investment picks
2015/1/19
HOUSTON , Jan.
Sign-up for Paragon Offshore Provides Fleet Status Report investment picks
2015/1/14
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1169268&ProfileId=051205&sourceType=1 PARSIPPANY, NJ --
Sign-up for Ogilvy CommonHealth Worldwide Takes Home Silver at PM360's Pharma Choice Awards investment picks
2014/12/18
http://www.ccnmatthews.com/logos/20110811-bdi-logo.jpg CALGARY, ALBERTA --
Sign-up for Black Diamond Group Limited Provides Operational Update investment picks
2015/1/20
The Board of Trustees of Alpine Total Dynamic Dividend Fund (NYSE:AOD), Alpine Global Dynamic Dividend Fund (NYSE:AGD) and Alpine Global Premier Properties Fund (NYSE:AWP) announced their same regular monthly distribution for the month of February 2015 as each had paid in the previous month.
Sign-up for Alpine Total Dynamic Dividend Fund, Alpine Global Dynamic Dividend Fund, Alpine Global Premier Properties Fund Declare Regular Monthly Distributions for February 2015 investment picks
2015/1/15
First shipments of Virtex UltraScale VU440 FPGA ideal for next-generation ASIC and Complex SOC prototyping and emulation SAN JOSE, Calif.
Sign-up for Xilinx Delivers the Industry's First 4M Logic Cell Device, Offering >50M Equivalent ASIC Gates and 4X More Capacity than Competitive Alternatives investment picks
2014/12/18
Strengthening Couche-Tard's Position in Attractive Southeastern and Gulf Coast United States LAVAL, QC and CARY, NC , Dec.
Sign-up for Alimentation Couche-Tard Inc. and The Pantry, Inc. Announce Definitive Merger Agreement investment picks
2014/12/4
Starbucks Coffee Company (NASDAQ: SBUX) chairman, president and chief executive officer Howard Schultz and other company leaders will detail Starbucks five-year strategic growth plan today at its biennial Investor Day, hosted at the company’s Support Center in Seattle for the first time in a decade.
Sign-up for Starbucks Details Five-Year Plan to Accelerate Profitable Growth and Extend Markets, Channels and Formats around the World at Biennial Investor Conference investment picks
2015/1/6
Prudential market experts expect moderate growth in 2015 – led by the United States – as global economies continue to recover.
Sign-up for Prudential experts: Investors should prepare for a lower return environment relative to historic returns investment picks
2015/1/12
Sundance Strategies, Inc. (OTCQB: SUND), an innovative company engaged in acquiring life insurance settlements and related insurance contracts, policies and obligations, today announced that it has appointed Kraig Higginson as its Executive Chairman of the Board.
Sign-up for Sundance Strategies Appoints Kraig Higginson Executive Chairman of the Board investment picks
2015/1/12
SAN DIEGO and BOISE, Idaho , Jan.
Sign-up for Robbins Arroyo LLP: Acquisition of MWI Veterinary Supply, Inc. (MWIV) by AmerisourceBergen Corporation (ABC) May Not Be in Shareholders' Best Interests investment picks
2015/1/7
NEW YORK , Jan.
Sign-up for AllianceBernstein Launches Multi-Manager Target-Date Series Co-managed with Morningstar Associates investment picks
2014/12/2
Diodes Incorporated (Nasdaq: DIOD), a leading global manufacturer and supplier of high-quality application specific standard products within the broad discrete, logic and analog semiconductor markets, today introduced a pair of compact 40V, 1A-rated gate drivers specifically designed to control the high-current power MOSFETs used in on-board and embedded power supplies and motor drive circuits.
Sign-up for MOSFET Gate Drivers from Diodes Incorporated Boosts Conversion Efficiency investment picks
2014/12/2
EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS ), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, today announced the launch of its first product, Infimab (BOW015), the first infliximab biosimilar in India.
Sign-up for EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches in India investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Ventas and American Realty Capital Healthcare Trust, Inc. Announce Definitive Election Deadline for HCT Stockholders to Make an Election to Receive Cash or Stock in the Merger to EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches in India
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent